22–23 Jul 2026
Heidelberg Congress Center
Europe/Berlin timezone

Randomized comparison of supervised exercise for lymphedema and related arm symptoms: SAFE trial exploratory analyses

22 Jul 2026, 12:00
1h 15m
Heidelberg Congress Center ( Heidelberg Congress Center )

Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany
1 - Scientific Poster Poster Session

Speaker

Kira Bloomquist (Center for Health Research UCSF), Copenhagen University Hospital, Rigshospitalet)

Description

Background
Exercise is increasingly recognized as beneficial in addressing breast cancer treatment-related sequelae including lymphedema. However, uncertainty remains regarding the safety of low levels of supervision. Currently, only supervised exercise is recommended for those at risk of, or with, lymphedema, yet head-to-head trials directly comparing supervision levels are limited. These exploratory analyses from the SAFE trial compared low- versus high-supervision exercise on breast cancer-related lymphedema prevalence and associated up-per-extremity symptoms.
Methods
Sixty women undergoing, or within five years of treatment for stage ll+ breast cancer were randomized to a 12-week, individually prescribed aerobic and resistance exercise program (target 150 minutes/week, moderate-intensity) with LOW (five in-person sessions) or HIGH (twenty in-person sessions) supervision. Outcomes included lymphedema prevalence (self-reported diagnosis and objectively measured via bioimpedance spectroscopy) and severity of fifteen upper-extremity symptoms related to lymphedema including heaviness, tightness and range of movement) (self-report, five-point scale ranging from 0 (none) to 4 (extreme)). Tests of statistical significance were 2-sided. Analyses followed intention-to-treat principals. Regis-tered at: Australian and New Zealand Clinical Trials Registry, ACTRN12616000547448

Results
Twenty participants were identified with lymphedema at baseline based on objective and/or self-report of a clinical diagnosis. At follow-up, there was no evidence to suggest that change in prevalence differed according to supervision level, irrespective of assessment method. Both groups maintained or improved most lymphedema-related arm symptoms, though po-tential for additional benefit in range of movement was observed in HIGH, with 52% reporting improvement versus 12% in LOW (P<0.05).
Conclusion
Though future studies are warranted to confirm findings, the results of this study indicate that breast cancer survivors with or at risk for lymphedema can benefit from exercise participa-tion, irrespective of low or high supervision. Overall results support the value of exercise, even at lower supervision levels, which may enhance the feasibility of wide-spread, equitable implementation of exercise services.

Keywords

Breast cancer, Exercise, Supervision, Lymphedema

Abstract submitters declaration yes
Conflict of Interest & Ethical Approval yes

Author

Kira Bloomquist (Center for Health Research UCSF), Copenhagen University Hospital, Rigshospitalet)

Co-authors

Dr Dimitrios Vagenas (School of Public Health and Social Work, Queensland University of Technology) Dr Christopher Pyke (Mater Health Services and Clinic Unit Faculty of Medicine) Dr Carolina Sandler (School of Health Sciences, University of New South Wales) Ms Sheree Rye (Cancer Council Queensland) Ms Leonie Young (The Wesley Hospital Choices Cancer Support Centre) Prof. Sandra Hayes (Cancer Council Queensland and Centre for Health Services Research, The University of Queensland) Dr Rosalind Spence (Cancer Council Queensland and School of Exercise and Nutrition Sciences, Faculty of Health, Queensland University of Technology)

Presentation materials

There are no materials yet.